Page last updated: 2024-08-24

pivalyloxymethyl butyrate and Angiogenesis, Pathologic

pivalyloxymethyl butyrate has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blank-Porat, D; Gruss-Fischer, T; Malik, Z; Nudelman, A; Rephaeli, A; Tarasenko, N	1

Other Studies

1 other study(ies) available for pivalyloxymethyl butyrate and Angiogenesis, Pathologic

Article	Year
The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties. Cancer letters, 2007, Oct-18, Volume: 256, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Proliferation; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Organophosphorus Compounds; Prodrugs; Prostatic Neoplasms; PTEN Phosphohydrolase; Receptor, ErbB-2; Tumor Cells, Cultured; Umbilical Veins	2007

Article

Year

The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties.

Cancer letters, 2007, Oct-18, Volume: 256, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Proliferation; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Organophosphorus Compounds; Prodrugs; Prostatic Neoplasms; PTEN Phosphohydrolase; Receptor, ErbB-2; Tumor Cells, Cultured; Umbilical Veins

2007